NCT07141563 2026-01-07
A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC
Bristol-Myers Squibb
Completed
Clinical Trials
8 trialsNCT06809374 2025-02-05
Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer
Kochi University
Completed
NCT02555813 2020-10-19
Treatment of Pancreatic Cancer With Abraxane
Celgene
Completed
NCT04133155 2020-03-13
Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer
Asan Medical Center
Completed
NCT04258163 2020-02-10
Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Completed
NCT01782690 2018-07-23
An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
Hoffmann-La Roche
Completed
NCT00419042 2013-10-01
Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)
Groupe Francais De Pneumo-Cancerologie
Completed
NCT00301301 2010-01-12
A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Royal Marsden NHS Foundation Trust
Completed